Lv4
595 积分 2021-04-02 加入
Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study
1年前
已完结
Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study
1年前
已完结
Efficacy and Safety of Different Doses of Rivaroxaban and Risk Factors for Bleeding in Elderly Patients with Venous Thromboembolism: A Real-World, Multicenter, Observational, Cohort Study
1年前
已完结
Molecular mechanisms of endothelial remodeling under doxorubicin treatment
1年前
已完结
Pharmacokinetic drug–drug interactions with direct anticoagulants in the management of cancer‐associated thrombosis
1年前
已完结
Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity: Insights from the AVERT trial
1年前
已完结
Primary prevention of cancer-associated venous thrombosis: Rationale and challenges in clinical practice
1年前
已完结
The prevalence of relevant drug-drug interactions and associated clinical outcomes in patients with cancer-associated thrombosis on concurrent anticoagulation and anticancer or supportive care therapies
1年前
已完结
Impact of mild thrombocytopenia on bleeding and recurrent thrombosis in cancer
1年前
已关闭
Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis
1年前
已完结
皖公网安备34019202002308
